1. Home
  2. CODX vs YCBD Comparison

CODX vs YCBD Comparison

Compare CODX & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Co-Diagnostics Inc.

CODX

Co-Diagnostics Inc.

HOLD

Current Price

$0.18

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Logo cbdMD Inc.

YCBD

cbdMD Inc.

HOLD

Current Price

$1.37

Market Cap

13.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CODX
YCBD
Founded
2013
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.6M
13.5M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
CODX
YCBD
Price
$0.18
$1.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$2.25
$2.00
AVG Volume (30 Days)
1.6M
31.6M
Earning Date
11-13-2025
12-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$507,892.00
$19,190,468.00
Revenue This Year
N/A
$6.94
Revenue Next Year
$18.89
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.47
52 Week High
$1.55
$6.54

Technical Indicators

Market Signals
Indicator
CODX
YCBD
Relative Strength Index (RSI) 30.03 53.88
Support Level $0.22 $1.31
Resistance Level $0.30 $1.79
Average True Range (ATR) 0.03 0.38
MACD -0.01 0.01
Stochastic Oscillator 2.05 38.52

Price Performance

Historical Comparison
CODX
YCBD

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

About YCBD cbdMD Inc.

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Share on Social Networks: